From COVID to pneumonic plague: mRNA vaccine scores another win with 100% effectiveness

In a major breakthrough, scientists from Tel Aviv University and the Israel Institute for Biological Research (IIBR) have created the world’s first mRNA-based vaccine to fight a deadly, antibiotic-resistant bacterium.Just like the COVID-19 shots, this vaccine uses lipid nanoparticles to deliver protection—and get this—it showed 100% effectiveness in animal trials against pneumonic plague, one of…

Read More

Appendix cancer is no longer rare for millennials and Gen Xers: Study |

Once regarded as exceedingly rare, appendix cancer, specifically appendiceal adenocarcinoma (AA), is now rising sharply in younger adults, especially among Gen X and millennials. A new retrospective study conducted by researchers at Vanderbilt University Medical Center and published in the Annals of Internal Medicine has brought this unsettling trend to light. What is Appendiceal Adenocarcinoma…

Read More